Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HUMAN MONOCLONAL ANTIBODY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 514 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tian, HJ; Xiao, Y; Zhu, M; Chen, YH
      HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Carrol, ED; Thomson, APJ; Hart, CA
      New therapies and vaccines for meningococcal disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Despond, O; Proulx, F; Carcillo, JA; Lacroix, J
      Pediatric sepsis and multiple organ dysfunction syndrome

      CURRENT OPINION IN PEDIATRICS
    4. Yang, XD; Jia, XC; Corvalan, JRF; Wang, P; Davis, CG
      Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    5. Mercier, JC; Bingen, E; Schlegel, N; Elion, J; Casanova, JL; Mira, JP; Beaufils, F
      Severe meningococcal shock with purpura fulminans: untoward result of genetic polymorphisms?

      ARCHIVES DE PEDIATRIE
    6. Miura, T; Katakura, Y; Seto, P; Zhang, YP; Teruya, K; Nishimura, E; Kato, M; Hashizume, S; Shirahata, S
      Availability of oncogene activated production system for mass production of light chain of human antibody in CHO cells

      CYTOTECHNOLOGY
    7. Saphire, EO; Parren, PWHI; Barbas, CF; Burton, DR; Wilson, IA
      Crystallization and preliminary structure determination of an intact humanimmunoglobulin, b12: an antibody that broadly neutralizes primary isolatesof HIV-1

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    8. Gilbert, P; Self, S; Rao, M; Naficy, A; Clemens, J
      Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    9. Harkin, DW; D'Sa, AABB; Yassin, MMI; Hoper, M; Halliday, MI
      Gut mucosal injury is attenuated by recombinant bactericidal/permeability-increasing protein in hind limb ischemia-reperfusion injury

      ANNALS OF VASCULAR SURGERY
    10. Patterson, LJ; Robey, F; Muck, A; Van Remoortere, K; Aldrich, K; Richardson, E; Alvord, WG; Markham, PD; Cranage, M; Robert-Guroff, M
      A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    11. Polonis, VR; De Souza, MS; Chanbancherd, P; Chantakulkij, S; Jugsudee, A; Loomis-Price, LD; Vancott, TC; Garner, R; Markowitz, LE; Brown, AE; Birx, DL
      HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    12. Boyce, N
      Is there a place for hyperimmune globulins in the treatment of refractory infections?

      TRANSFUSION MEDICINE REVIEWS
    13. Sprong, T; Stikkelbroeck, N; van der Ley, P; Steeghs, L; van Alphen, L; Klein, N; Netea, MG; van der Meer, JWM; van Deuren, M
      Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatorycytokine response

      JOURNAL OF LEUKOCYTE BIOLOGY
    14. Pawlotsky, JM
      Virus of hepatitis C and immune response

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    15. McLain, L; Brown, JL; Cheung, L; Reading, SA; Parry, C; Jones, TD; Cleveland, SM; Dimmock, NJ
      Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutantof human immunodeficiency virus type 1

      ARCHIVES OF VIROLOGY
    16. Urbani, S; Uggeri, J; Matsuura, Y; Miyamura, T; Penna, A; Boni, C; Ferrari, C
      Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens

      HEPATOLOGY
    17. Crowe, JE; Suara, RO; Brock, S; Kallewaard, N; House, F; Weitkamp, JH
      Genetic and structural determinants of virus neutralizing antibodies

      IMMUNOLOGIC RESEARCH
    18. Koda, K; Glassy, MC; McNight, ME; Yasutomi, J; Saito, N; Dan, M; Nakajima, N
      Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1

      ANTICANCER RESEARCH
    19. Xiao, Y; Lu, Y; Chen, YH
      Epitope-vaccine as a new strategy against HIV-1 mutation

      IMMUNOLOGY LETTERS
    20. Numasaki, M; Nakamura, K; Fukuoka, Y; Saeki, H; Hanai, N; Kudo, T
      Nucleotide sequence analysis of a human monoclonal antibody TONO-1 with cytotoxic potential for T-leukemia/lymphoma cells

      IMMUNOLOGY LETTERS
    21. Kasuga, H; Ito, Y; Sakamoto, S; Kawachi, H; Shimizu, F; Yuzawa, Y; Matsuo, S
      Effects of anti-TGF-beta type II receptor antibody on experimental glomerulonephritis

      KIDNEY INTERNATIONAL
    22. Eckert, DM; Kim, PS
      Mechanisms of viral membrane fusion and its inhibition

      ANNUAL REVIEW OF BIOCHEMISTRY
    23. Hofmann-Lehmann, R; Rasmussen, RA; Vlasak, J; Smith, BA; Baba, TW; Liska, V; Montefiori, DC; McClure, HM; Anderson, DC; Bernacky, BJ; Rizvi, TA; Schmidt, R; Hill, LR; Keeling, ME; Katinger, H; Stiegler, G; Posner, MR; Cavacini, LA; Chou, TC; Ruprecht, RM
      Passive immunization against oral AIDS virus transmission: An approach to prevent mother-to-infant HIV-1 transmission?

      JOURNAL OF MEDICAL PRIMATOLOGY
    24. Spenlehauer, C; Gordon, CA; Trkola, A; Moore, JP
      A luciferase-reporter gene-expressing T-cell line facilitates neutralization and drug-sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1

      VIROLOGY
    25. Saphire, EO; Parren, PWHI; Pantophlet, R; Zwick, MB; Morris, GM; Rudd, PM; Dwek, RA; Stanfield, RL; Burton, DR; Wilson, IA
      Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design

      SCIENCE
    26. Hensel, F; Hermann, R; Brandlein, S; Krenn, V; Schmausser, B; Geis, S; Muller-Hermelink, HK; Vollmers, HP
      Regulation of the new coexpressed CD55 (decay-accelerating factor) receptor on stomach carcinoma cells involved in antibody SC-1-induced apoptosis

      LABORATORY INVESTIGATION
    27. Si, ZH; Cayabyab, M; Sodroski, J
      Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys

      JOURNAL OF VIROLOGY
    28. Cho, MW; Kim, YB; Lee, MK; Gupta, KC; Ross, W; Plishka, R; Buckler-White, A; Igarashi, T; Theodore, T; Byrum, R; Kemp, C; Montefiori, DC; Martin, MA
      Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

      JOURNAL OF VIROLOGY
    29. Spenlehauer, C; Kirn, A; Aubertin, AM; Moog, C
      Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: Investigation of the mechanism of inhibition

      JOURNAL OF VIROLOGY
    30. Beaumont, T; van Nuenen, A; Broersen, S; Blattner, WA; Lukashov, VV; Schuitemaker, H
      Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course

      JOURNAL OF VIROLOGY
    31. Yang, XZ; Wyatt, R; Sodroski, J
      Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers

      JOURNAL OF VIROLOGY
    32. Hezareh, M; Hessell, AJ; Jensen, RC; van de Winkel, JGJ; Parren, PWHI
      Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    33. Earl, PL; Sugiura, W; Montefiori, DC; Broder, CC; Lee, SA; Wild, C; Lifson, J; Moss, B
      Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140

      JOURNAL OF VIROLOGY
    34. Malenbaum, SE; Yang, D; Cheng-Mayer, C
      Evidence for similar recognition of the conserved neutralization epitopes of human immunodeficiency virus type 1 envelope gp120 in humans and macaques

      JOURNAL OF VIROLOGY
    35. Parren, PWHI; Marx, PA; Hessell, AJ; Luckay, A; Harouse, J; Cheng-Mayer, C; Moore, JP; Burton, DR
      Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

      JOURNAL OF VIROLOGY
    36. Scharf, O; Golding, H; King, LR; Eller, N; Frazier, D; Golding, B; Scott, DE
      Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1

      JOURNAL OF VIROLOGY
    37. Zwick, MB; Bonnycastle, LLC; Menendez, A; Irving, MB; Barbas, CF; Parren, PWHI; Burton, DR; Scott, JK
      Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12

      JOURNAL OF VIROLOGY
    38. Chen, CH; Jin, L; Zhu, CB; Holz-Smith, S; Matthews, TJ
      Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate

      JOURNAL OF VIROLOGY
    39. Moore, JP; Parren, PWHI; Burton, DR
      Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

      JOURNAL OF VIROLOGY
    40. Montefiori, DC; Safrit, JT; Lydy, SL; Barry, AP; Bilska, M; Vo, HTT; Klein, M; Tartaglia, J; Robinson, HL; Rovinski, B
      Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques

      JOURNAL OF VIROLOGY
    41. Morimoto, K; Schnell, MJ; Pulmanausahakul, R; McGettigan, JP; Foley, HD; Faber, M; Hooper, DC; Dietzschold, B
      High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector

      JOURNAL OF IMMUNOLOGICAL METHODS
    42. Drew, PD; Moss, MT; Pasieka, TJ; Grose, C; Harris, WJ; Porter, AJR
      Multimeric humanized varicella-zoster virus antibody fragments to gH neutralize virus while monomeric fragments do not

      JOURNAL OF GENERAL VIROLOGY
    43. Babcock, GJ; Mirzabekov, T; Wojtowicz, W; Sodroski, J
      Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes

      JOURNAL OF BIOLOGICAL CHEMISTRY
    44. Sanlioglu, S; Williams, CM; Samavati, L; Butler, NS; Wang, GS; McCray, PB; Ritchie, TC; Hunninghake, GW; Zandi, E; Engelhardt, JF
      Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B

      JOURNAL OF BIOLOGICAL CHEMISTRY
    45. Takekoshi, M; Maeda, F; Nagatsuka, Y; Aotsuka, S; Ono, Y; Ihara, S
      Cloning and expression of human anti-tumor necrosis factor-alpha monoclonal antibodies from Epstein-Barr virus transformed oligoclonal libraries

      JOURNAL OF BIOCHEMISTRY
    46. Kolb-Maurer, A; Unkmeir, A; Kammerer, U; Hubner, C; Leimbach, T; Stade, A; Kampgen, E; Frosch, M; Dietrich, G
      Interaction of Neisseria meningitidis with human dendritic cells

      INFECTION AND IMMUNITY
    47. Nagatsuka, Y; Kasama, T; Ohashi, Y; Uzawa, J; Ono, Y; Shimizu, K; Hirabayashi, Y
      A new phosphoglycerolipid, 'phosphatidylglucose', found in human cord red cells by multi-reactive monoclonal anti-i cold agglutinin, mAb GL-1/GL-2

      FEBS LETTERS
    48. Zhang, WT; Godillot, AP; Wyatt, R; Sodroski, J; Chaiken, I
      Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4

      BIOCHEMISTRY
    49. Patterson, LJ; Aberdeen, A; Kone, J; Haben, M; Raymond, M; Berkower, I
      Formation of HIV-1 envelope-hepatitis B core antigen hybrids with high affinity for CD4

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    50. Hoon, DSB; Kuo, CT; Wen, SH; Wang, H; Metelitsa, L; Reynolds, CP; Seeger, RC
      Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow

      AMERICAN JOURNAL OF PATHOLOGY
    51. Cao, JN; Gao, TW; Stanbridge, EJ; Irie, R
      RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    52. Achkar, JM; Wang, XH; Nyambi, P; Gorny, MK; Zolla-Pazner, S; Bandres, JC
      Polymerase chain reaction-based assay for antibody-mediated neutralizationof HIV-1 reveals a population of nonneutralized virus undetected by conventional p24 assay

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    53. Maynard, J; Georgiou, G
      Antibody engineering

      ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
    54. Sibbald, WJ
      An alternative pathway for preclinical research in fluid management

      CRITICAL CARE
    55. Freeman, BD; Natanson, C
      Anti-inflammatory therapies in sepsis and septic shock

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    56. Nunberg, JH; Follis, KE; Trahey, M; LaCasse, RA
      Turning a corner on HIV neutralization?

      MICROBES AND INFECTION
    57. Glemain, P
      Intent to treat.

      PROGRES EN UROLOGIE
    58. Mondelli, MU
      Immunopathogenesis of viral hepatitis

      CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
    59. Abiko, Y
      Passive immunization against dental caries and periodontal disease: Development of recombinant and human monoclonal antibodies

      CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE
    60. Edgeworth, RL; Ugen, KE
      Immunopathological factors for vertical transmission of HIV-1

      PATHOBIOLOGY
    61. Dubois, MJ; Vincent, JL
      Clinically-oriented therapies in sepsis: a review

      JOURNAL OF ENDOTOXIN RESEARCH
    62. Ding, J; Lu, Y; Chen, YH
      Candidate multi-epitope vaccines in aluminium adjuvant induce high levels of antibodies with predefined multi-epitope specificity against HIV-1

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    63. Inoue, Y; Kawamoto, S; Shoji, M; Hashizume, S; Teruya, K; Katakura, Y; Shirahata, S
      Properties of ras-amplified recombinant BHK-21 cells in protein-free culture

      CYTOTECHNOLOGY
    64. Inoue, Y; Fujisawa, M; Shoji, M; Hashizume, S; Katakura, Y; Shirahata, S
      Enhanced antibody production of human-human hybridomas by retinoic acid

      CYTOTECHNOLOGY
    65. Frances, V; Guret, C; Malisan, F; Peyron, E; Ho, S; Maat, MJ; Fossiez, F; Nicolas, JF; Lebecque, S; Matinez-Valdez, H
      The human anti-bullous pemphigoid monoclonal autoantibody P22 is encoded by genes of the IGHV4 and IGHV4 families

      JOURNAL OF AUTOIMMUNITY
    66. Bures, R; Gaitan, A; Zhu, TF; Graziosi, C; McGrath, KM; Tartaglia, J; Caudrelier, P; EL Habib, R; Klein, M; Lazzarin, A; Stablein, DM; Deers, M; Corey, L; Greenberg, ML; Schwartz, DH; Montefiori, DC
      Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generateantibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    67. Stamatatos, L; Lim, M; Cheng-Mayer, C
      Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptibleprimary HIV type 1 isolates

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    68. Connolly, AB; Vernon, DR
      Manipulations of the metabolic response for management of patients with severe surgical illness: Review

      WORLD JOURNAL OF SURGERY
    69. Marshall, JC
      Clinical trials of mediator-directed therapy in sepsis: what have we learned?

      INTENSIVE CARE MEDICINE
    70. Parren, PWHI; Poignard, P; Ditzel, HJ; Williamson, RA; Burton, DR
      Antibodies in human infectious disease

      IMMUNOLOGIC RESEARCH
    71. Lockey, TD; Slobod, KS; Caver, TE; D'Costa, S; Owens, RJ; McClure, HM; Compans, RW; Hurwitz, JL
      Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees

      IMMUNOLOGIC RESEARCH
    72. Cheng, XJ; Watanabe, K; Ihara, S; Takekoshi, M; Tachibana, H
      Bacterial expression of a human monoclonal antibody that inhibits in vitroadherence of Entamoeba histolytica trophozoites

      ARCHIVES OF MEDICAL RESEARCH
    73. Little, M; Kipriyanov, SM; Le Gall, F; Moldenhauer, G
      Of mice and men: hybridoma and recombinant antibodies

      IMMUNOLOGY TODAY
    74. Nicacio, CD; Lundkvist, A; Sjolander, KB; Plyusnin, A; Salonen, EM; Bjorling, E
      A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus

      JOURNAL OF MEDICAL VIROLOGY
    75. Shinmoto, H; Yamagishi, K; Kimura, T; Suzuki, M
      Epitope analysis of a rice allergen with a monoclonal antibody secreted bya human-mouse hybridoma

      BIOTECHNOLOGY LETTERS
    76. Dorn, J; Masciotra, S; Yang, CF; Downing, R; Biryahwaho, B; Mastro, TD; Nkengasong, J; Pieniazek, D; Rayfield, MA; Hu, DJ; Lal, RB
      Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection

      JOURNAL OF CLINICAL MICROBIOLOGY
    77. Bunnell, E; Lynn, M; Habet, K; Neumann, A; Perdomo, CA; Friedhoff, LT; Rogers, SL; Parrillo, JE
      A lipid A analog, E5531, blocks the endotoxin response in human volunteerswith experimental endotoxemia

      CRITICAL CARE MEDICINE
    78. Mathiak, G; Szewczyk, D; Abdullah, F; Ovadia, P; Feuerstein, G; Rabinovici, R
      An improved clinically relevant sepsis model in the conscious rat

      CRITICAL CARE MEDICINE
    79. Nydegger, UE; Mohacsi, PJ; Escher, R; Morell, A
      Clinical use of intravenous immunoglobulins

      VOX SANGUINIS
    80. Mosier, DE
      Human xenograft models for virus infection

      VIROLOGY
    81. Viveros, M; Dickey, C; Cotropia, JP; Gevorkian, G; Larralde, C; Broliden, K; Levi, M; Burgess, A; Cao, CH; Weiner, DB; Agadjanyan, MG; Ugen, KE
      Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41

      VIROLOGY
    82. Binley, JM; Clas, B; Gettie, A; Vesanen, M; Montefiori, DC; Sawyer, L; Booth, J; Lewis, M; Marx, PA; Bonhoeffer, S; Moore, JP
      Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia

      VIROLOGY
    83. Gherardi, CR
      New therapeutic approaches to sepsis. Illusions, failures and errors

      MEDICINA-BUENOS AIRES
    84. Moulard, M; Lortat-Jacob, H; Mondor, I; Roca, G; Wyatt, R; Sodroski, J; Lu, Z; Olson, W; Kwong, PD; Sattentau, QJ
      Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

      JOURNAL OF VIROLOGY
    85. Fouts, TR; Tuskan, R; Godfrey, K; Reitz, M; Hone, D; Lewis, GK; DeVico, AL
      Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex

      JOURNAL OF VIROLOGY
    86. Malenbaum, SE; Yang, D; Cavacini, L; Posner, M; Robinson, J; Cheng-Mayer, C
      The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors

      JOURNAL OF VIROLOGY
    87. Beaumont, T; Broersen, S; van Nuenen, AD; Huisman, HG; Husman, AMD; Heeney, JL; Schuitemaker, H
      Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees

      JOURNAL OF VIROLOGY
    88. Ly, A; Stamatatos, L
      V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCRS receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies

      JOURNAL OF VIROLOGY
    89. Sanders, RW; Schiffner, L; Master, A; Kajumo, F; Guo, Y; Dragic, T; Moore, JP; Binley, JM
      Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bondbetween the gp120 and gp41 subunits

      JOURNAL OF VIROLOGY
    90. Stiehm, ER; Fletcher, CV; Mofenson, LM; Palumbo, PE; Kang, MH; Fenton, T; Sapan, CV; Meyer, WA; Shearer, WT; Hawkins, E; Fowler, MG; Bouquin, P; Purdue, L; Sloand, EM; Nemo, GJ; Wara, D; Bryson, YJ; Starr, SE; Petru, A; Burchett, S
      Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273)

      JOURNAL OF INFECTIOUS DISEASES
    91. Kawahara, H; Maeda-Yamamoto, M; Hakamata, K
      Effective induction and acquisition of human monoclonal IgE antibodies reactive with house-dust mite extracts

      JOURNAL OF IMMUNOLOGICAL METHODS
    92. Cleveland, SM; Jones, TD; Dimmock, NJ
      Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1

      JOURNAL OF GENERAL VIROLOGY
    93. Cheng, XJ; Ihara, S; Takekoshi, M; Tachibana, H
      Entamoeba histolytica: Bacterial expression of a human monoclonal antibodywhich inhibits in vitro adherence of trophozoites

      EXPERIMENTAL PARASITOLOGY
    94. Uronen, H; Williams, AJ; Dixon, G; Andersen, SR; Van Der Ley, P; Van Deuren, M; Callard, RE; Klein, N
      Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS)

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    95. Vincent, JL
      Update on sepsis: Pathophysiology and treatment

      ACTA CLINICA BELGICA
    96. Oral, HB; Akdis, CA
      Antibody-based therapies in infectious diseases

      DIAGNOSTIC AND THERAPEUTIC ANTIBODIES
    97. Rubinstein, A; Mizrachi, Y; Pettoello-Mantovani, M; Lenz, J; Liu, GQ; Rubinstein, Y; Goldstein, H; Yust, I; Burke, M; Vardinon, N; Spirer, Z; Cryz, SJ
      Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    98. Turbica, I; Simon, F; Barin, F
      Antibodies to the CD4-binding site of HIV-1 gp120 in patients infected by variants belonging to the M or O group

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    99. Timmermann, W; Thiede, A; Illert, B; Muller-Hermelink, NK; Vollmers, HP; Krenn, V; Reindl, L; Wilhelm, M
      Additive immunotherapy of gastric cancer using antibody-induced apoptosis

      LANGENBECKS ARCHIVES OF SURGERY
    100. Zimmermann, M; Busch, K; Kuhn, S; Zeppezauer, M
      Endotoxin adsorbent based on immobilized human serum albumin

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 05:19:14